Latest Market News
Stocks, crypto, forex, commodities and ETFs — filtered, timestamped and curated by the XInvest News desk
-
Pfizer Stock at $24.25 Tests Value Thesis With 7.1% Yield
Pfizer shares are hovering near a 52-week low while offering a 7.1% dividend yield, one of the richest payouts in…
-
Solana at $81 Tests Key Breakout as ETFs Top $1 Billion
Solana is trading near $81 and pressing against a critical resistance zone after months of range-bound trading. Institutional custody, spot…
-
BlackRock IBIT Leads $510 Million Bitcoin ETF Rebound
U.S. spot Bitcoin ETFs posted roughly $510 million of inflows over three sessions in early July, ending a 10-day $2.73…
-
SPY Nears $760 Record as S&P 500 Posts Best Week in Two Months
SPY traded around $754, roughly 1% below its all-time high, after the S&P 500 gained 1.7% in its strongest week…
-
XRP ETFs Draw $1.44 Billion as XRP Holds Near $1.10
U.S. spot XRP ETFs have absorbed about $1.44 billion and locked away more than 800 million tokens since November 2025.…
-
Novo Nordisk Stock at $50: Wegovy Pill Fuels Recovery Amid Lilly Pressure
Novo Nordisk shares have rebounded from a 52-week low of $35.12 to about $50, but remain roughly 75% below their…
-
SK Hynix Nasdaq Listing Raises $26.5 Billion as AI Trade Faces a Key Test
SK Hynix priced its Nasdaq listing at $149 per ADR, raising $26.5 billion in the biggest foreign U.S. listing on…
-
Bitcoin Holds $62,500 as Fed Decision Nears and ETF Flows Stay Fragile
Bitcoin is hovering near key long-term support around $62,500 as investors weigh weak ETF flows, major resistance near $65,000, and…
-
Gold Price Tests $4,094 as Fed Outlook and Iran Risk Pull XAU/USD in Opposite Directions
Gold price hovered near $4,098 after testing $4,094, leaving XAU/USD about 27% below its January 29 peak of $5,602. Investors…
-
EUR/USD Defends $1.1400 Before July ECB and Fed Decisions
EUR/USD is hovering near $1.1420 as traders focus on the critical $1.1400 support level ahead of key inflation data and…
-
AstraZeneca Shares Drop 5.7% After Wainua Phase 3 Trial Miss
AstraZeneca lost about $24 billion in market value after Wainua failed a pivotal Phase 3 heart trial. Investors are now…
-
Ethereum Price at $1,796 Faces July 29 Fed Test After 64% Drop
Ethereum rebounded to about $1,796, but the move still leaves ETH roughly 64% below its 2025 peak. Traders are now…